Scientific Advisory Board

The quality of research at the Max Planck Institute for Molecular Genetics is regularly evaluated by a Scientific Advisory Board. The members of this board are internationally renowned scientists appointed by the president of the Max Planck Society. They generally do not belong to the Max Planck Society.

Members of the Scientific Advisory Board (appointment period 2020 - 2022)

Prof. Dr. Wouter de Laat
Hubrecht Institute
Utrecht, Netherlands

Prof. Dr. Dame Amanda Fisher
Imperial College London
Institute of Clinical Sciences, Hammersmith Hospital
London, UK

Prof. Dr. Markus Grompe
Oregon Health & Science University
Oregon Stem Cell Center
Portland, Oregon, USA

Dr. Christina Leslie
Memorial Sloan Kettering Cancer Center
Computational and Systems Biology Program
New York, NY, USA

Prof. Dr. Lynne E. Maquat
University of Rochester Medical Center
School of Medicine and Dentistry
Rochester, NY, USA

Prof. Dr. Hanah Margalit
The Hebrew University of Jerusalem
Department of Microbiology and Molecular Genetics
Jerusalem, Israel

Prof. Dr. Andrew McMahon
University of Southern California
Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research
Los Angeles, CA, USA

Prof. Dr. Joe Nadeau (Chair)
Center for Molecular Medicine
Maine Medical Center Research Institute
Scarborough, ME, USA

Prof. Dr. Chris Ponting
University of Edingburgh
MRC Institute of Genetics and Molecular Medicine
Western General Hospital
Edinburgh, UK

Prof. A.J. Marian Walhout, PhD
University of Massachusetts Medical School
Albert Sherman Center
Worcester, MA, USA

Go to Editor View